Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial
Anne Hege Aamodt, Member Board of Directors at European Stroke Organisation, shared on LinkedIn:
”Published today in The New England Journal of Medicine: the TenCRAOS trial.
We asked a difficult but important question: can early intravenous thrombolysis with tenecteplase improve vision after acute central retinal artery occlusion?
In this randomized phase 3 trial, the answer was no — and treatment was associated with serious safety concerns.
Negative trials matter.
TenCRAOS provides much-needed high-level evidence in a field where treatment decisions are often made under great uncertainty.
These results should inform clinical practice and future guidelines.
Deeply grateful to our multidisciplinary teams in neurology and ophthalmology for an inspiring collaboration, and to all investigators, supporters, and funders — and especially to the patients who generously participated.”
Read the full article here.
Article: A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
Authors: Stephen J. Ryan; Øystein Kalsnes Jørstad; Mona Skjelland; Maiju Pesonen; Claus Z. Simonsen; Toke Bek; Rolf Ankerlund Blauenfeldt, Anne Hege Aamodt et al., for the TenCRAOS Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis